| 
 |  | N-Acetyl carnosine Basic information |  
  
 |  | N-Acetyl carnosine Chemical Properties |  
 | Melting point  | 209-210°C |  | Boiling point  | 775.9±60.0 °C(Predicted) |  | density  | 1.343±0.06 g/cm3(Predicted) |  | storage temp.  | Sealed in dry,2-8°C |  | solubility  | Methanol (Slightly), Water (Slightly) |  | form  | Solid |  | pka | 3.08±0.10(Predicted) |  | color  | White to Off-White |  | InChI | InChI=1/C11H16N4O4/c1-7(16)13-3-2-10(17)15-9(11(18)19)4-8-5-12-6-14-8/h5-6,9H,2-4H2,1H3,(H,12,14)(H,13,16)(H,15,17)(H,18,19)/t9-/s3 |  | InChIKey | BKAYIFDRRZZKNF-DJEYLCQNNA-N |  | SMILES | [C@H](C(=O)O)(NC(=O)CCNC(=O)C)CC1N=CNC=1 |&1:0,r| |  
  
 |  | N-Acetyl carnosine Usage And Synthesis |  
 | Description | N-acetyl-L-Carnosine is a dipeptide and acetylated form of L-carnosine that has been found in heart and skeletal muscle and has antioxidant and anticataract activities. It reduces iron- and ascorbate-induced malondialdehyde (MDA) accumulation in liposomes when used at concentrations of 10 and 20 mM. Topical administration of N-acetyl-L-carnosine (1% v/v) reduces cortical opacities in a canine model of age-related cataracts. |  | Chemical Properties | White Crystalline Solid |  | Uses | N-acetyl-L-Carnosine is used in the treatment of cataracts and in the treatment of UV-induced immunosuppression
 |  | Definition | ChEBI: A dipeptide that is the N-acetyl derivative of carnosine. |  
  
 |  | N-Acetyl carnosine Preparation Products And Raw materials |  
  
 
 |